Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-02418-0003-0000-0 |
Chemical Name: | Methdilazine hydrochloride |
CASRN: | 1229-35-2 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 714394_SCE |
Study Result: | Equivocal |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Negative |
No Activation | 2 | Positive |
No Activation | 3 | Negative |
Induced Rat Liver S9 | 1_S9 | |
Induced Rat Liver S9 | 2_S9 | Questionable |
Induced Rat Liver S9 | 3_S9 | Negative |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Water | 0 | 50 | 1029 | 518 | 0.503 | 10.36 | 25.7 | 0.000 |
Test Chemical | Methdilazine hydrochloride | 0.5 | 50 | 1022 | 440 | 0.431 | 8.80 | 25.7 | -14.476 |
1.67 | 50 | 1030 | 419 | 0.407 | 8.38 | 25.7 | -19.191 | ||
5 | 50 | 1035 | 388 | 0.375 | 7.76 | 25.7 | -25.531 | ||
16.7 | 0 | 0 | 0 | 0.000 | 0.00 | 0.0 | N/A | ||
Positive Control | Mitomycin-C | 0.001 | 50 | 1033 | 678 | 0.656 | 13.56 | 25.7 | 30.381 |
Mitomycin-C | 0.01 | 5 | 105 | 196 | 1.867 | 39.20 | 25.7 | 270.811 | |
Trend: | -4.494 | ||||||||
Probability: | 1.000 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Water | 0 | 50 | 1035 | 403 | 0.389 | 8.06 | 25.5 | 0.000 |
Test Chemical | Methdilazine hydrochloride | 17.4 | 50 | 1035 | 423 | 0.409 | 8.46 | 25.5 | 4.963 |
20.2 | 50 | 1030 | 492 | 0.478 | 9.84 | 36.5 | 22.677 | ||
25.2 | 50 | 1014 | 499 | 0.492 | 9.98 | 36.5 | 26.386 | ||
Positive Control | Mitomycin-C | 0.001 | 50 | 1038 | 657 | 0.633 | 13.14 | 25.5 | 62.556 |
Mitomycin-C | 0.01 | 5 | 105 | 262 | 2.495 | 52.40 | 25.5 | 540.837 | |
Trend: | 3.984 | ||||||||
Probability: | 0.000 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Water | 0 | 50 | 1018 | 396 | 0.389 | 7.92 | 25.5 | 0.000 |
Test Chemical | Methdilazine hydrochloride | 12.5 | 50 | 1024 | 424 | 0.414 | 8.48 | 25.5 | 6.443 |
15 | 50 | 1014 | 448 | 0.442 | 8.96 | 30.3 | 13.578 | ||
17.4 | 0 | 0 | 0 | 0.000 | 0.00 | 30.3 | N/A | ||
19.8 | 0 | 0 | 0 | 0.000 | 0.00 | 0.0 | N/A | ||
Positive Control | Mitomycin-C | 0.001 | 50 | 1017 | 558 | 0.549 | 11.16 | 25.5 | 41.048 |
Mitomycin-C | 0.01 | 5 | 103 | 205 | 1.990 | 41.00 | 25.5 | 411.646 | |
Trend: | 1.848 | ||||||||
Probability: | 0.032 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Water | 0 | 50 | 1030 | 469 | 0.455 | 9.38 | 25.7 | 0.000 |
Test Chemical | Methdilazine hydrochloride | 16.7 | 50 | 1033 | 461 | 0.446 | 9.22 | 25.7 | -1.991 |
50 | 0 | 0 | 0 | 0.000 | 0.00 | 0.0 | N/A | ||
Trend: | -0.307 | ||||||||
Probability: | 0.620 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Water | 0 | 50 | 1045 | 406 | 0.389 | 8.12 | 25.5 | 0.000 |
Test Chemical | Methdilazine hydrochloride | 15.1 | 50 | 1041 | 465 | 0.447 | 9.30 | 25.5 | 14.972 |
20.1 | 50 | 1033 | 505 | 0.489 | 10.10 | 25.5 | 25.829 | ||
30 | 50 | 1039 | 443 | 0.426 | 8.86 | 25.5 | 9.743 | ||
40 | 0 | 0 | 0 | 0.000 | 0.00 | 0.0 | N/A | ||
Positive Control | Cyclophosphamide | 0.3 | 50 | 1035 | 654 | 0.632 | 13.08 | 25.5 | 62.640 |
Cyclophosphamide | 2 | 5 | 104 | 210 | 2.019 | 42.00 | 25.5 | 419.728 | |
Trend: | 1.504 | ||||||||
Probability: | 0.066 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Water | 0 | 50 | 1034 | 451 | 0.436 | 9.02 | 25.4 | 0.000 |
Test Chemical | Methdilazine hydrochloride | 20.1 | 50 | 1040 | 409 | 0.393 | 8.18 | 25.4 | -9.836 |
24.9 | 50 | 1029 | 466 | 0.453 | 9.32 | 25.4 | 3.828 | ||
30 | 50 | 1020 | 498 | 0.488 | 9.96 | 25.4 | 11.937 | ||
35.1 | 0 | 0 | 0 | 0.000 | 0.00 | 0.0 | N/A | ||
Positive Control | Cyclophosphamide | 0.3 | 50 | 1028 | 615 | 0.598 | 12.30 | 25.4 | 37.160 |
Cyclophosphamide | 2 | 5 | 104 | 128 | 1.231 | 25.60 | 25.4 | 182.176 | |
Trend: | 2.362 | ||||||||
Probability: | 0.009 |